A feasibility study on violence prevention in outpatients with schizophrenia

International Journal of Law and Psychiatry
Ulrich FrommbergerTilman Steinert

Abstract

Patients with schizophrenia have an increased risk of violent behavior, and occupy a large percentage of forensic beds. Most patients in forensic psychiatry have already undergone general psychiatric therapy. This predestinates general psychiatrists to identify those patients presenting such a risk, and to try to intervene so that violence can be prevented. Feasibility study of violence prevention using cognitive-behavioral therapy interventions in male patients with schizophrenia on a general psychiatric ward. Of our patients admitted with schizophrenia, 39.1% had committed violent acts against others; the severity of the act was usually low. The percentage of non-participants was high (83.1%). Study subjects were younger, had not been ill for as long, and were less apt to drop out of the ongoing general psychiatric treatment than the non-participants. Study subjects and non-participants did not differ in the violent act's severity. Our therapy manual proved to be sensible and practical. Those of us attempting to prevent schizophrenic patients from committing violence must deal with individuals who are generally hard to reach. We succeeded in achieving a low drop-out rate after having recruited patients who had displayed a sub...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1986·The American Journal of Psychiatry·S C YudofskyD Williams
Aug 1, 1994·The American Journal of Psychiatry·D P BernsteinJ Ruggiero
Sep 9, 1999·Schizophrenia Bulletin·C ArangoA Calcedo Ordóñez
May 12, 2000·Archives of General Psychiatry·P A BrennanS Hodgins
May 29, 2000·The British Journal of Psychiatry : the Journal of Mental Science·J W SwansonB J Burns
Jun 16, 2000·Pharmacopsychiatry·T SteinertR P Gebhardt
Feb 24, 2001·The Journal of Nervous and Mental Disease·E H FischerJ W Goethe
Aug 28, 2001·International Journal of Law and Psychiatry·S Hodgins
Jan 14, 2003·The Journal of Clinical Psychiatry·Diana O Perkins
Sep 1, 2004·The American Journal of Psychiatry·Peter F BuckleyKelly Camlin-Shingler
Sep 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·S Hodgins, R Müller-Isberner
May 3, 2006·Archives of General Psychiatry·Jeffrey W SwansonJeffrey A Lieberman
Oct 3, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Eric B ElbogenJohn Monahan
Nov 17, 2006·The New England Journal of Medicine·Richard A Friedman
Oct 2, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Sheilagh HodginsTimothy Mak
Jan 30, 2008·Der Nervenarzt·T Steinert, J Bergk
Feb 3, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Gillian HaddockNicholas Tarrier
Mar 17, 2009·The Journal of Clinical Psychiatry·Seena FazelNiklas Långström
Apr 21, 2009·Acta Psychiatrica Scandinavica·J KoskinenJ Miettunen
Aug 12, 2009·PLoS Medicine·Seena FazelMartin Grann
Dec 1, 2009·The Psychiatric Clinics of North America·J P Lindenmayer, Isabella Kanellopoulou
Feb 9, 2013·International Journal of Law and Psychiatry·Tilman Steinert, Richard Whittington
Mar 8, 2014·Der Nervenarzt·S Hodgins, R Müller-Isberner
Apr 4, 2014·Journal of Psychiatric Research·Tania Josiane BosquiCiaran Mulholland
Jul 14, 2016·JAMA Psychiatry·Jan Volavka
Jul 14, 2016·JAMA Psychiatry·Amir SariaslanSeena Fazel
Nov 12, 2016·The Psychiatric Clinics of North America·Kayla Fisher
Feb 23, 2017·Neuropsychiatric Disease and Treatment·Xiaoli TangJunjie Huang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.